Overview
- Reviews the imaging features of selected classes of pharmaceuticals and drugs
- Numerous rich images Explanation of the implications of imaging findings for the neuroradiologist and the clinician
- Illustrative discussion of pertinent differential diagnoses
- Coverage of related topics including contrast agents, molecular imaging, and drug delivery methods
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (55 chapters)
-
Front Matter
Keywords
About this book
This book reviews the imaging features associated with selected classes of pharmaceuticals and drugs on brain, head and neck, and spine and explains the implications of the imaging findings for the neuroradiologist and the clinician. Some agents produce characteristic abnormalities with distinctive imaging features, while others have a spectrum of manifestations on imaging. Still further agents produce rather nonspecific changes on imaging, requiring a differential diagnosis. In this book, informative cases are depicted by rich images, with concise accompanying explanatory text that reviews the class of agent and the mechanism of action and discusses image interpretation and its significance.
Editors and Affiliations
Bibliographic Information
Book Title: Neuroimaging Pharmacopoeia
Editors: Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer
DOI: https://doi.org/10.1007/978-3-319-12715-6
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2015
Softcover ISBN: 978-3-319-34362-4Published: 08 October 2016
eBook ISBN: 978-3-319-12715-6Published: 17 February 2015
Edition Number: 1
Number of Pages: XVIII, 382
Number of Illustrations: 286 b/w illustrations, 31 illustrations in colour
Topics: Neuroradiology, Pharmacology/Toxicology